Related Experiment Video
Updated: Feb 24, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Emergence of the Molds Other than Aspergillus in Immunocompromised Patients
1Division of Infectious Diseases, Duke University Medical Center, 315 Trent Drive, PO Box 102359, Durham, NC 27710, USA.
Abstract:
Immunocompromised patients are at high risk for invasive fungal infections (IFIs); although Aspergillus remains the most common IFI caused by molds, other fungi, such as Mucorales, dematiaceous molds, and Fusarium spp, are being seen with increasing frequency. Presentations can vary, but sinopulmonary and disseminated infections are common. Our understanding of the pathogenesis of these infections is rudimentary. Fungal cultures and histopathology remain the backbone of diagnostics, as no good serologic markers are available. Polymerase chain reaction tests are being developed but currently remain investigational. Management of these infections is usually multidisciplinary, requiring surgical debridement along with antifungal therapy.
Insights
Immunocompromised patients face high risks for invasive fungal infections (IFIs). While Aspergillus is common, emerging fungal pathogens require multidisciplinary management including antifungals and surgery.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Host
Background:
- Invasive fungal infections (IFIs) pose a significant threat to immunocompromised patients.
- Aspergillus species are the most frequent mold-causing IFIs, but non-Aspergillus molds like Mucorales, dematiaceous molds, and Fusarium are increasing.
Purpose of the Study:
- To review the current landscape of IFIs in immunocompromised individuals.
- To highlight the challenges in diagnosis and management of these infections.
Main Methods:
- Review of current literature on IFIs in immunocompromised patients.
- Discussion of diagnostic modalities including fungal cultures, histopathology, and emerging PCR tests.
Main Results:
- Sinopulmonary and disseminated infections are common presentations of IFIs.
- Pathogenesis of many IFIs remains poorly understood.
- Current diagnostics rely heavily on culture and histopathology; serologic markers are lacking.
Conclusions:
- Management of IFIs is complex, often requiring a multidisciplinary approach.
- Treatment involves surgical debridement and antifungal therapy.
- Further research is needed to improve diagnostic tools and understand pathogenesis.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Phylum Microsporidia
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

